Stockreport

Novo Nordisk's Christmas Gift To Shareholders: The Wegovy Pill Has Been Approved [Seeking Alpha]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF The Wegovy pill delivers 16.6% weight loss in 64 weeks, outpacing Eli Lilly's Orforglipron and offering long-term cardiovascular benefits. NVO will enjoy at least 90 [Read more]